Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment.

Saved in:
Bibliographic Details
Title: Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment.
Authors: Hundley WG; Division of Cardiology, Pauley Heart Center, Virginia Commonwealth University, Richmond., D'Agostino R Jr; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC., Crotts T; Section on Cardiovascular Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC., Craver K; Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC., Hackney MH; Division of Hematology, Oncology and Palliative Care, Massey Cancer Center, Virginia Commonwealth University, Richmond., Jordan JH; Division of Cardiology, Pauley Heart Center, Virginia Commonwealth University, Richmond.; Department of Biomedical Engineering, Virginia Commonwealth University, Richmond., Ky B; Department of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Wagner LI; Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC., Herrington DM; Section on Cardiovascular Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC., Yeboah J; Section on Cardiovascular Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC., Reding KW; Department of Biobehavioral Nursing and Health Informatics, School of Nursing, University of Washington, Seattle., Ladd AC; Division of Cardiology, Pauley Heart Center, Virginia Commonwealth University, Richmond., Rapp SR; Department of Psychiatry and Behavioral Medicine, Wake Forest School of Medicine, Winston-Salem, NC., Russo S; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD., O'Connell N; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC., Weaver KE; Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC., Dressler EV; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC., Ge Y; Department of Software and Information Systems, University of North Carolina, Charlotte., Melin SA; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC., Gudena V; Division of Hematology and Oncology, Cone Health, Greensboro, NC., Lesser GJ; Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC.
Source: NEJM evidence [NEJM Evid] 2022 Sep; Vol. 1 (9). Date of Electronic Publication: 2022 Aug 18.
Publication Type: Journal Article
Journal Info: Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2766-5526 (Electronic) Linking ISSN: 27665526 NLM ISO Abbreviation: NEJM Evid Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2766-5526
DOI:10.1056/evidoa2200097